Hosted on MSN
Engineered T-cells that express both CARs and TCRs can better distinguish between cancerous and healthy tissues
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to ...
(L to R) Corresponding author Brian Abraham, PhD, and co-first authors Kelsey Maher, PhD, and co-first author Jie Lu, PhD, all of the St. Jude Department of Computational Biology. Cells express ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results